Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2 .

Autor: Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Kotsopoulos J; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Domchek SM; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Terry MB; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY., Chamberlain JA; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia., Bassett JK; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia., Aeilts AM; Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Buys SS; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA., Eisen AF; Odette Cancer Centre, Sunnybrook Health Sciences, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada., Foulkes WD; Department of Human Genetics, McGill University, Montreal, QC, Canada., Friedlander ML; Department of Medical Oncology, Prince of Wales and Royal Hospital for Women, Sydney, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia., Gronwald J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Hopper JL; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., John EM; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Karlan BY; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA.; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA., Kim RH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network and Sinai Health, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada., Kurian AW; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Metcalfe K; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada.; Bloomberg School of Nursing, University of Toronto, Toronto, ON, Canada., Nathanson KL; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Singer CF; Department of Obstetrics and Gynecology and Center for Breast Health, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Symecko H; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA., Tung N; Beth Israel Deaconess Medical Center, Boston, MA., Narod SA; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Milne RL; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 02, pp. JCO2400176. Date of Electronic Publication: 2024 Oct 02.

Impact of ¹⁸ F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer.

Autor: Dayes IS; Department of Oncology, McMaster University, Hamilton, ON, Canada.; Juravinski Cancer Centre-Hamilton Health Sciences, Hamilton, ON, Canada.; Ontario Clinical Oncology Group, Hamilton, ON, Canada.; Escarpment Cancer Research Institute, Hamilton, ON, Canada., Metser U; Joint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.; University Health Network Princess Margaret Cancer Centre, Toronto, ON, Canada., Hodgson N; Department of Surgery, McMaster University, Hamilton, ON, Canada., Parpia S; Department of Oncology, McMaster University, Hamilton, ON, Canada.; Ontario Clinical Oncology Group, Hamilton, ON, Canada.; Escarpment Cancer Research Institute, Hamilton, ON, Canada., Eisen AF; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Sunnybrook Health Sciences Centre-Odette Cancer Centre, Toronto, ON, Canada.; Ontario Health, Toronto, ON, Canada., George R; Department of Surgery, University of Toronto, Toronto, ON, Canada.; St Michael's Hospital, Toronto, ON, Canada., Blanchette P; Department of Oncology, Western University, London, ON, Canada.; London Health Sciences Regional Cancer Program, London, ON, Canada., Cil TD; University Health Network Princess Margaret Cancer Centre, Toronto, ON, Canada.; Department of Surgery, University of Toronto, Toronto, ON, Canada., Arnaout A; Department of Surgery, Ottawa University, Ottawa, ON, Canada.; Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Chan A; Northern Ontario School of Medicine, Thunder Bay ON, Canada.; Thunder Bay Regional Health Sciences Cancer Centre, Thunder Bay, ON, Canada., Levine MN; Department of Oncology, McMaster University, Hamilton, ON, Canada.; Juravinski Cancer Centre-Hamilton Health Sciences, Hamilton, ON, Canada.; Ontario Clinical Oncology Group, Hamilton, ON, Canada.; Escarpment Cancer Research Institute, Hamilton, ON, Canada.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Aug 10; Vol. 41 (23), pp. 3909-3916. Date of Electronic Publication: 2023 May 26.

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.

Autor: Brackstone M; London Health Sciences Centre, London, Ontario, Canada., Baldassarre FG; Program in Evidence-Based Care, McMaster University, Hamilton, Ontario, Canada., Perera FE; London Health Sciences Centre, London, Ontario, Canada., Cil T; University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada., Chavez Mac Gregor M; University of Texas MD Anderson Cancer Center, Houston, TX., Dayes IS; Juravinski Cancer Centre, Hamilton, Ontario, Canada., Engel J; Cancer Center of Southeastern Ontario, Kingston General Hospital, Kingston, Ontario, Canada., Horton JK; Research Triangle Park, Chapel Hill, NC., King TA; Dana Farber/Brigham & Women's Cancer Center, Boston, MA., Kornecki A; Western University, London, Ontario, Canada., George R; Division of General Surgery, St Michael's Hospital, CIBC Breast Centre, Toronto, Ontario, Canada., SenGupta SK; Pathology Department, Kingston General Hospital, Kingston, Ontario, Canada., Spears PA; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Eisen AF; University of Toronto, Odette Cancer Centre, Toronto, Ontario, Canada.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Sep 20; Vol. 39 (27), pp. 3056-3082. Date of Electronic Publication: 2021 Jul 19.